C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.

OBJECTIVE:The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. DESIGN:Nested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, tre...

Full description

Bibliographic Details
Main Authors: Mark W Tenforde, Nikhil Gupte, David W Dowdy, David M Asmuth, Ashwin Balagopal, Richard B Pollard, Patcharaphan Sugandhavesa, Javier R Lama, Sandy Pillay, Sandra W Cardoso, Jyoti Pawar, Breno Santos, Cynthia Riviere, Noluthando Mwelase, Cecilia Kanyama, Johnstone Kumwenda, James G Hakim, Nagalingeswaran Kumarasamy, Robert Bollinger, Richard D Semba, Thomas B Campbell, Amita Gupta, ACTG PEARLS and NWCS 319 Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4342263?pdf=render
id doaj-7846c2a4c66a479997e5e3fb2bed1f56
record_format Article
spelling doaj-7846c2a4c66a479997e5e3fb2bed1f562020-11-24T21:49:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01102e011742410.1371/journal.pone.0117424C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.Mark W TenfordeNikhil GupteDavid W DowdyDavid M AsmuthAshwin BalagopalRichard B PollardPatcharaphan SugandhavesaJavier R LamaSandy PillaySandra W CardosoJyoti PawarBreno SantosCynthia RiviereNoluthando MwelaseCecilia KanyamaJohnstone KumwendaJames G HakimNagalingeswaran KumarasamyRobert BollingerRichard D SembaThomas B CampbellAmita GuptaACTG PEARLS and NWCS 319 Study GroupOBJECTIVE:The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. DESIGN:Nested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, treatment-naïve adults in 9 countries. We compared cases (participants with incident TB diagnosed by 96 weeks) to a random sample of controls (participants who did not develop TB, stratified by country and treatment arm). METHODS:We measured pre-ART C-reactive protein (CRP), EndoCab IgM, ferritin, interferon gamma (IFN-γ), interleukin 6 (IL-6), interferon gamma-inducible protein 10 (IP-10), lipopolysaccharide (LPS), soluble CD14 (sCD14), tumor necrosis factor alpha (TNF-α), and CD4/DR+/38+ and CD8/DR+/38+ T cells. Markers were defined according to established cutoff definitions when available, 75th percentile of measured values when not, and detectable versus undetectable for LPS. Using logistic regression, we measured associations between biomarkers and incident TB, adjusting for age, sex, study site, treatment arm, baseline CD4 and log10 viral load. We assessed the discriminatory value of biomarkers using receiver operating characteristic (ROC) analysis. RESULTS:Seventy-seven persons (4.9%) developed incident TB during follow-up. Elevated baseline CRP (aOR 3.25, 95% CI: 1.55-6.81) and IP-10 (aOR 1.89, 95% CI: 1.05-3.39), detectable plasma LPS (aOR 2.39, 95% CI: 1.13-5.06), and the established TB risk factors anemia and hypoalbuminemia were independently associated with incident TB. In ROC analysis, CRP, albumin, and LPS improved discrimination only modestly for TB risk when added to baseline routine patient characteristics including CD4 count, body mass index, and prior TB. CONCLUSION:Incident TB occurs commonly after ART initiation. Although associated with higher post-ART TB risk, baseline CRP, IP-10, and LPS add limited value to routine patient characteristics in discriminating who develops active TB. Besides determining ideal cutoffs for these biomarkers, additional biomarkers should be sought that predict TB disease in ART initiators.http://europepmc.org/articles/PMC4342263?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Mark W Tenforde
Nikhil Gupte
David W Dowdy
David M Asmuth
Ashwin Balagopal
Richard B Pollard
Patcharaphan Sugandhavesa
Javier R Lama
Sandy Pillay
Sandra W Cardoso
Jyoti Pawar
Breno Santos
Cynthia Riviere
Noluthando Mwelase
Cecilia Kanyama
Johnstone Kumwenda
James G Hakim
Nagalingeswaran Kumarasamy
Robert Bollinger
Richard D Semba
Thomas B Campbell
Amita Gupta
ACTG PEARLS and NWCS 319 Study Group
spellingShingle Mark W Tenforde
Nikhil Gupte
David W Dowdy
David M Asmuth
Ashwin Balagopal
Richard B Pollard
Patcharaphan Sugandhavesa
Javier R Lama
Sandy Pillay
Sandra W Cardoso
Jyoti Pawar
Breno Santos
Cynthia Riviere
Noluthando Mwelase
Cecilia Kanyama
Johnstone Kumwenda
James G Hakim
Nagalingeswaran Kumarasamy
Robert Bollinger
Richard D Semba
Thomas B Campbell
Amita Gupta
ACTG PEARLS and NWCS 319 Study Group
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
PLoS ONE
author_facet Mark W Tenforde
Nikhil Gupte
David W Dowdy
David M Asmuth
Ashwin Balagopal
Richard B Pollard
Patcharaphan Sugandhavesa
Javier R Lama
Sandy Pillay
Sandra W Cardoso
Jyoti Pawar
Breno Santos
Cynthia Riviere
Noluthando Mwelase
Cecilia Kanyama
Johnstone Kumwenda
James G Hakim
Nagalingeswaran Kumarasamy
Robert Bollinger
Richard D Semba
Thomas B Campbell
Amita Gupta
ACTG PEARLS and NWCS 319 Study Group
author_sort Mark W Tenforde
title C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
title_short C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
title_full C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
title_fullStr C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
title_full_unstemmed C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
title_sort c-reactive protein (crp), interferon gamma-inducible protein 10 (ip-10), and lipopolysaccharide (lps) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description OBJECTIVE:The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. DESIGN:Nested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, treatment-naïve adults in 9 countries. We compared cases (participants with incident TB diagnosed by 96 weeks) to a random sample of controls (participants who did not develop TB, stratified by country and treatment arm). METHODS:We measured pre-ART C-reactive protein (CRP), EndoCab IgM, ferritin, interferon gamma (IFN-γ), interleukin 6 (IL-6), interferon gamma-inducible protein 10 (IP-10), lipopolysaccharide (LPS), soluble CD14 (sCD14), tumor necrosis factor alpha (TNF-α), and CD4/DR+/38+ and CD8/DR+/38+ T cells. Markers were defined according to established cutoff definitions when available, 75th percentile of measured values when not, and detectable versus undetectable for LPS. Using logistic regression, we measured associations between biomarkers and incident TB, adjusting for age, sex, study site, treatment arm, baseline CD4 and log10 viral load. We assessed the discriminatory value of biomarkers using receiver operating characteristic (ROC) analysis. RESULTS:Seventy-seven persons (4.9%) developed incident TB during follow-up. Elevated baseline CRP (aOR 3.25, 95% CI: 1.55-6.81) and IP-10 (aOR 1.89, 95% CI: 1.05-3.39), detectable plasma LPS (aOR 2.39, 95% CI: 1.13-5.06), and the established TB risk factors anemia and hypoalbuminemia were independently associated with incident TB. In ROC analysis, CRP, albumin, and LPS improved discrimination only modestly for TB risk when added to baseline routine patient characteristics including CD4 count, body mass index, and prior TB. CONCLUSION:Incident TB occurs commonly after ART initiation. Although associated with higher post-ART TB risk, baseline CRP, IP-10, and LPS add limited value to routine patient characteristics in discriminating who develops active TB. Besides determining ideal cutoffs for these biomarkers, additional biomarkers should be sought that predict TB disease in ART initiators.
url http://europepmc.org/articles/PMC4342263?pdf=render
work_keys_str_mv AT markwtenforde creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT nikhilgupte creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT davidwdowdy creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT davidmasmuth creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT ashwinbalagopal creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT richardbpollard creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT patcharaphansugandhavesa creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT javierrlama creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT sandypillay creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT sandrawcardoso creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT jyotipawar creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT brenosantos creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT cynthiariviere creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT noluthandomwelase creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT ceciliakanyama creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT johnstonekumwenda creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT jamesghakim creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT nagalingeswarankumarasamy creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT robertbollinger creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT richarddsemba creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT thomasbcampbell creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT amitagupta creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
AT actgpearlsandnwcs319studygroup creactiveproteincrpinterferongammainducibleprotein10ip10andlipopolysaccharidelpsareassociatedwithriskoftuberculosisafterinitiationofantiretroviraltherapyinresourcelimitedsettings
_version_ 1725887822234124288